1. Home
  2. HRZN vs IRWD Comparison

HRZN vs IRWD Comparison

Compare HRZN & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Horizon Technology Finance Corporation

HRZN

Horizon Technology Finance Corporation

N/A

Current Price

$4.24

Market Cap

295.1M

Sector

Finance

ML Signal

N/A

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

N/A

Current Price

$3.67

Market Cap

741.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HRZN
IRWD
Founded
2008
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
295.1M
741.8M
IPO Year
N/A
2009

Fundamental Metrics

Financial Performance
Metric
HRZN
IRWD
Price
$4.24
$3.67
Analyst Decision
Hold
Hold
Analyst Count
5
5
Target Price
$6.80
$4.94
AVG Volume (30 Days)
1.4M
2.8M
Earning Date
01-01-0001
05-26-2026
Dividend Yield
30.99%
N/A
EPS Growth
N/A
1400.00
EPS
N/A
0.15
Revenue
N/A
$298,276,000.00
Revenue This Year
$19.99
$57.95
Revenue Next Year
$27.95
$4.39
P/E Ratio
N/A
$24.50
Revenue Growth
N/A
8.88
52 Week Low
$4.00
$0.55
52 Week High
$9.52
$5.78

Technical Indicators

Market Signals
Indicator
HRZN
IRWD
Relative Strength Index (RSI) 17.25 42.86
Support Level N/A $3.08
Resistance Level $6.81 $3.93
Average True Range (ATR) 0.25 0.33
MACD -0.21 -0.01
Stochastic Oscillator 9.57 44.41

Price Performance

Historical Comparison
HRZN
IRWD

About HRZN Horizon Technology Finance Corporation

Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

Share on Social Networks: